Imperva Inc (NYSE:IMPV) had its price objective upped by equities research analysts at Monness Crespi & Hardt from $55.00 to $57.00 in a report released on Friday. The firm currently has a “buy” rating on the software maker’s stock. Monness Crespi & Hardt’s price target would suggest a potential upside of 18.26% from the stock’s current price.

Several other equities research analysts also recently weighed in on the stock. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the stock a “buy” rating in a report on Friday. BidaskClub downgraded shares of Imperva from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 5th. ValuEngine downgraded shares of Imperva from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Zacks Investment Research downgraded shares of Imperva from a “buy” rating to a “hold” rating in a report on Tuesday, May 9th. Finally, UBS AG began coverage on shares of Imperva in a report on Tuesday, June 6th. They issued a “positive” rating and a $60.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the stock. Imperva presently has an average rating of “Hold” and an average price target of $50.39.

Shares of Imperva (NYSE IMPV) opened at 48.20 on Friday. The firm’s market cap is $1.61 billion. Imperva has a 52 week low of $34.40 and a 52 week high of $57.24. The company has a 50 day moving average of $49.12 and a 200 day moving average of $45.04.

Imperva (NYSE:IMPV) last released its quarterly earnings results on Thursday, July 27th. The software maker reported $0.24 EPS for the quarter, topping the consensus estimate of $0.05 by $0.19. The business had revenue of $74.44 million during the quarter, compared to analyst estimates of $74.30 million. Imperva had a net margin of 31.92% and a return on equity of 36.67%. The company’s quarterly revenue was up 28.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.23) earnings per share. On average, equities research analysts anticipate that Imperva will post $0.45 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Monness Crespi & Hardt Raises Imperva Inc (IMPV) Price Target to $57.00” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2017/07/28/monness-crespi-hardt-raises-imperva-inc-impv-price-target-to-57-00.html.

In other Imperva news, CRO Michael D. Mooney sold 52,356 shares of the company’s stock in a transaction dated Wednesday, May 10th. The shares were sold at an average price of $47.51, for a total transaction of $2,487,433.56. Following the completion of the sale, the executive now directly owns 52,356 shares of the company’s stock, valued at $2,487,433.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Sunil D. Nagdev sold 4,857 shares of the company’s stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $49.00, for a total transaction of $237,993.00. Following the sale, the senior vice president now directly owns 16,290 shares of the company’s stock, valued at $798,210. The disclosure for this sale can be found here. Insiders have sold 60,302 shares of company stock valued at $2,875,861 over the last ninety days. Insiders own 2.20% of the company’s stock.

Several institutional investors have recently modified their holdings of the stock. Kalmar Investments Inc. DE increased its position in shares of Imperva by 0.4% in the first quarter. Kalmar Investments Inc. DE now owns 39,808 shares of the software maker’s stock worth $1,634,000 after buying an additional 140 shares in the last quarter. Aperio Group LLC increased its position in shares of Imperva by 8.1% in the second quarter. Aperio Group LLC now owns 7,114 shares of the software maker’s stock worth $340,000 after buying an additional 531 shares in the last quarter. US Bancorp DE increased its position in shares of Imperva by 11.7% in the second quarter. US Bancorp DE now owns 6,016 shares of the software maker’s stock worth $287,000 after buying an additional 630 shares in the last quarter. American International Group Inc. increased its position in shares of Imperva by 7.1% in the first quarter. American International Group Inc. now owns 17,657 shares of the software maker’s stock worth $725,000 after buying an additional 1,167 shares in the last quarter. Finally, Teachers Advisors LLC increased its position in shares of Imperva by 2.6% in the first quarter. Teachers Advisors LLC now owns 48,482 shares of the software maker’s stock worth $1,990,000 after buying an additional 1,220 shares in the last quarter. Institutional investors own 92.72% of the company’s stock.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.